Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional near-infrared spectroscopy (fNIRS). By comparing brain activity across different groups and relating it to symptom severity, this study aims to improve our understanding of how these conditions affect the brain.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• 18 years and older

• Ability to provide written informed consent

• Adequate cognitive and language abilities to understand and complete study tasks, including clinical assessments and fNIRS procedures

• Confirmed clinical diagnosis of major depressive disorder, bipolar disorder, or mild cognitive impairment (MCI)

• Stable psychiatric or cognitive condition, without acute episodes requiring immediate intervention

• Healthy control

• o No past or current psychiatric or cognitive disorder

• Major depressive disorder (MDD):

‣ Diagnosis of major depressive disorder, confirmed through clinical evaluation.

⁃ No history of bipolar disorder or psychotic symptoms.

• Bipolar disorder:

• o Diagnosis of bipolar disorder I or II, confirmed through clinical evaluation.

• Mild Cognitive Impairment (MCI):

‣ Pre-existing clinical diagnosis of mild cognitive impairment, supported by neuropsychological testing and/or MRI, PET scan data.

⁃ No history of major psychiatric disorders, such as major depression, bipolar disorder or schizophrenia.

Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Sarah M. Williams
Williams.Sarah2@mayo.edu
507-422-2972
Time Frame
Start Date: 2025-03-26
Estimated Completion Date: 2028-03-30
Participants
Target number of participants: 200
Treatments
Healthy Controls
o No past or current psychiatric or cognitive disorder.
Major Depressive Disorder
* Diagnosis of major depressive disorder, confirmed through clinical evaluation.~* No history of bipolar disorder or psychotic symptoms.
Bipolar Disorder
o Diagnosis of bipolar disorder I or II, confirmed through clinical evaluation.
Mild Cognitive Impairment (MCI)
* Pre-existing clinical diagnosis of mild cognitive impairment, supported by neuropsychological testing and/or MRI, PET scan data.~* No history of major psychiatric disorders, such as major depression, bipolar disorder or schizophrenia.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov

Similar Clinical Trials